TRANSLATIONAL IMPACT
Clinical issue
Brain and neural tube defects are among the most common human congenital malformations. One prominent example is the Chiari malformation (CM), a developmental defect characterized by abnormal growth of the brainstem and cerebellar herniation. CMs can be asymptomatic or can cause a wide range of clinical conditions. Malformations may, for instance, cause severe neural tube defects and hydrocephalus, in turn leading to incapacitating or lethal conditions. CMs and most other congenital brain defects have a pronounced genetic basis and a complex inheritance pattern. The genetic causes of these defects, and the molecular interplay between known environmental risk factors (for example, folic acid deficiency) and susceptibility genes are currently ill defined.
Results
In this study, the authors identify two genetic factors that cause Chiari-like malformations in mice. One of these genes, Suz12, is a member of a polycomb complex, a group of proteins that act as epigenetic regulators of gene expression. In comparison to normal, wild-type mice, which have two copies of Suz12, mice with only one copy of Suz12 have brain and neural tube defects. Some of the Suz12 heterozygotes show cerebellar herniation and an enlarged brainstem accompanied by occipital cortical alterations and spina bifida, almost perfectly resembling CM as seen in some human patients. The most impaired mice have downward displacement of the cerebellum, which causes hydrocephalus. The authors also demonstrate that Zac1 (also known as Plagl1 or Lot1), a regulator of neuronal proliferation, is part of the same molecular pathway affected by Suz12 deficiency.
Implications and future directions
Polycomb proteins are starting to be recognized as having a key role in human disease; this study demonstrates that polycomb protein complexes can play a role in nervous system malformations as well. This work strongly suggests that developmental brain abnormalities such as CMs can result from altered epigenetic regulation of genes involved in cell proliferation in the brain.
Article navigation
Related articles
Cited by...
More in this TOC section
Similar articles
Other journals from The Company of Biologists
DMM and COVID-19
We are aware that the COVID-19 pandemic is having an unprecedented impact on researchers worldwide. The Editors of all The Company of Biologists’ journals have been considering ways in which we can alleviate concerns that members of our community may have around publishing activities during this time. Read about the actions we are taking at this time.
Please don’t hesitate to contact the Editorial Office if you have any questions or concerns.
Monica Justice bids farewell to DMM
In her farewell Editorial, outgoing Editor-in-Chief Monica Justice reminds us of the past half-decade of growth and of DMM's commitment to support the disease modelling community, concluding, “The knowledge and experience I gained during my time as Senior Editor and EiC at DMM is invaluable: working within a not-for-profit community publishing environment is a joy.”
3D imaging of beta cell mass in diabetic mouse models
In their inducible mouse model of diabetes, Roostalu et al. demonstrate how quantitative light-sheet imaging can capture changes in individual islets to help pharmacological research in diabetes.
Visit our YouTube channel to watch more videos from DMM, our sister journals and the Company.
Modelling Joubert syndrome patient-derived mutations in C. elegans
In this issue’s Editor’s choice, Karen Lange and colleagues used C. elegans to model and characterise two patient-derived mutations that cause the ciliopathy Joubert syndrome.
Interview – Karen Lange
First author of our current Editor’s choice, Karen Lange takes us behind the scenes of the paper, and shares her thoughts on how the lack of both time and job security will impact her research.